Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BioArctic | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 17.94B | -101.2x | 0.63 | SEK 201.80 | -7.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Devyser Diagnostics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.89B | -34.9x | 2.27 | SEK 109.50 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.6% Upside | Upgrade to Pro+ | |
BioInvent International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.77B | -4.2x | 0.14 | SEK 26.90 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vicore Pharma Holding AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.69B | -5.9x | -0.17 | SEK 7.21 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hansa Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.49B | -1.7x | -0.1 | SEK 22.04 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Egetis Therapeutics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.46B | -3.6x | -0.32 | SEK 4.07 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cereno Scientific | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.35B | -13.6x | 0.2 | SEK 4.80 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XSpray Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.10B | -3.4x | 0.15 | SEK 30.10 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intellego Technologies AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.04B | 13.7x | 1.05 | SEK 35.10 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanoform Finland Plc | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 998.51M | -3.7x | 0.61 | SEK 12.18 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Diamyd Medical | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 852.48M | -5.2x | 0.56 | SEK 8.19 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Saniona AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 784.35M | 3.9x | 0.02 | SEK 6.86 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SynAct Pharma AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 784.14M | -8.1x | -0.15 | SEK 15.35 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.3% Upside | Upgrade to Pro+ | |
Hamlet Pharma AB | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 753.38M | -16.6x | 1.21 | SEK 4.15 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abliva AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 709.23M | -6.6x | -0.35 | SEK 0.44 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0% Upside | Upgrade to Pro+ | |
Nykode Therapeutics | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 675.40M | -1.9x | SEK 13.98 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Promimic AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 533.60M | -39.7x | 1.13 | SEK 26.10 | -8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prolight Diagnostics | NGM | Healthcare | Biotechnology & Medical Research | SEK 480.23M | -14.9x | -0.25 | SEK 0.68 | -15.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cantargia AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 397.78M | -1.8x | -0.06 | SEK 1.59 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Peptonic Medical | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 345.56M | -0.4x | -0.01 | SEK 0.004 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncopeptides | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 343.87M | -0.9x | -0.03 | SEK 1.60 | 6.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.9% Upside | Upgrade to Pro+ | |
Mendus AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 338.21M | -2.5x | -0.07 | SEK 6.72 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Initiator Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 334.14M | -17.5x | -0.38 | SEK 5.95 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AlzeCure Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 295.79M | -7.3x | -0.23 | SEK 3.37 | 28.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ascelia Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 283.51M | -2x | -0.07 | SEK 2.88 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Xintela | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 247.68M | -5.5x | -0.15 | SEK 0.37 | -7.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NextCell Pharma AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 244.13M | -3.7x | -0.19 | SEK 3.18 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curasight AS | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 241.45M | -4.8x | 0.12 | SEK 11.59 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alzinova | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 240.75M | -8.8x | -0.49 | SEK 2.74 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Xbrane Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 214.51M | -0.6x | -0.01 | SEK 0.14 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guard Therapeutics | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 195.49M | -1.8x | -0.1 | SEK 16.70 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biovica International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 163.11M | -1.1x | -0.03 | SEK 1.67 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medivir B | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 160.40M | -0.05 | SEK 1.41 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Annexin Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 159.89M | -2.7x | -0.06 | SEK 0.30 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SenzaGen | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 154.90M | -8x | -0.32 | SEK 5.25 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Klaria Pharma Holding AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 154.17M | -2.7x | 0.56 | SEK 1.07 | -9.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kancera AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 140.58M | -3x | -0.08 | SEK 1.17 | -7.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.1% Upside | Upgrade to Pro+ | |
Alligator Bioscience | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 136.93M | -0x | -0.02 | SEK 0.008 | -13.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lumito AB | NGM | Healthcare | Biotechnology & Medical Research | SEK 129.23M | -2.7x | 0.07 | SEK 0.49 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bio-Works | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 123.18M | -1.9x | -0.06 | SEK 1.58 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AroCell | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 112.88M | -2.7x | -0.1 | SEK 0.49 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biosergen AS | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 99.80M | -5.3x | -0.07 | SEK 0.38 | -10.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abera Bioscience | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 97.33M | -62.7x | -0.94 | SEK 5.92 | -6.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.9% Upside | Upgrade to Pro+ | |
Sprint Bioscience AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 94.26M | -5.2x | 0 | SEK 1.35 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Active Biotech | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 88.57M | -0.8x | -0.05 | SEK 0.07 | -7.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coegin Pharma AB | NGM | Healthcare | Biotechnology & Medical Research | SEK 88.07M | -2x | -0.08 | SEK 4.32 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dextech Medical | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 78.38M | -15.7x | 6.14 | SEK 4.02 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intervacc | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 71.57M | -1x | -0.03 | SEK 0.98 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Spago Nanomedical AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 69.64M | -1.8x | -0.03 | SEK 0.20 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acousort | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 54.51M | -3.7x | -0.17 | SEK 3.65 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |